Company / Current Assets per Share
Lineage Cell Therapeutics, Inc. Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$0.27
FY2025
5-year range
$0.23 / $0.73
FY2021-FY2025
Trend
-7.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share has fluctuated over the past 10 years, ranging from $0.23 in FY2023 to $0.73 in FY2021.
Based on SEC 10-K filings.
0.27 in FY2025 with a 5-year CAGR of -1.8%.
Improved from $0.23 to $0.27 over the past 2 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -8.8%
- 5-Year CAGR
- -1.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current assets per share decreased 7.9% year-over-year.
- Peak current assets per share was recorded in FY2021.
- Lowest current assets per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -3.82 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.27 | -7.9% |
| FY2024 | $0.29 | +29.0% |
| FY2023 | $0.23 | -36.2% |
| FY2022 | $0.35 | -51.4% |
| FY2021 | $0.73 | +148.1% |
| FY2020 | $0.29 | -35.1% |
| FY2019 | $0.45 | +57.9% |
| FY2018 | $0.29 | -30.9% |
| FY2017 | $0.41 | +46.2% |
| FY2016 | $0.28 | -53.0% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026